2011-03-24T12:02:58-05:00 2010-06-30 DELOITTE TAX LLP 100 PEABODY PLACE STE 800 MEMPHIS TN 38103 990 2009-07-01 351044585 AMERICAN LEBANESE SYRIAN ASSOCIATED CHARITIES INC AMER 9015782000 501 St Jude Place Memphis TN 381050000 JEFFREY T PEARSON 9015782000 2011-03-24 1 9013226700 2009 2016-02-24 21:20:13Z Richard C Shadyac Jr 501 St Jude Place Memphis TN 381050000 914651868 0 X www.stjude.org X 1957 TN TO RAISE FUNDS TO SUPPORT ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. 46 41 1511 1000000 832925 -302010 658106230 659370821 0 -19667758 60324160 21493767 21727585 659932239 741422566 380735099 408161189 0 75966559 77341689 4309991 5992249 140898937 146404000 151404207 607415649 642899334 52516590 98523232 1752545419 1975083262 36689601 37932110 1715855818 1937151152 American Lebanese Syrian Associated Charities, Inc. (ALSAC) was founded in 1957 and exists for the sole purpose of raising funds to support the current and future operating and maintenace needs of St. Jude Children's Research Hospital, Inc. 0 0 448914179 408161189 ALSAC is the fundraising organization of St. Jude Children's Research Hospital. ALSAC exists solely to raise and provide the funds necessary to operate and maintain St. Jude. Because of ALSAC, families never pay for treatments that are not covered by insurance and no child is ever denied treatment because of the family's inability to pay. It costs $1.5 million a day to operate St. Jude, and more than 70 percent of St. Jude's operating budget is covered by public contributions generated by ALSAC fundraising programs.St. Jude has been recognized as the nation's most trusted charity by Harris Interactive and as the top children's cancer hospital by U.S. News and World Report. St. Jude is the first and only pediatric cancer center to be designated as a Comprehensive Cancer Center by the National Cancer Institute.When St. Jude opened its doors in 1962, it was the first pediatric cancer research institution to place doctors, scientists and patients "all under one roof," creating a worldwide model for "bench-to-bedside" research and treatment of childhood cancers and other life-threatening diseases.Since that time, St. Jude revolutionized the way the world treats childhood cancer. St. Jude developed protocols that have helped push overall survival rates for childhood cancers from less than 20 percent, when the hospital opened in 1962, to 80 percent today.Today, St. Jude continues to lead the way in finding cures for deadly childhood diseases through research and treatment. St. Jude has embarked on an unprecedented effort to sequence the pediatric cancer genome and to identify the genetic changes that give rise to some of the world's deadliest childhood cancers. And St. Jude continues to uphold its promise of conducting world-class research and providing first-class patient care, regardless of the family's ability to pay. Most of the funding for St. Jude protocols is not covered by insurance. St. Jude covers those costs along with other costs a family typically incurs while their child is being treated at the hospital. This includes travel, housing and food. St. Jude also maintains a school program to provide opportunities for patients to continue their normal educational activities and to provide re-entry services to ease the transition back to the community school.Every child saved at St. Jude means children saved around the world-a direct result of cutting-edge research and treatment that set the standard in treating childhood cancers. And discoveries made at St. Jude are shared freely with doctors and scientists all over the world.In addition to childhood cancer, St. Jude plays a critical leadership role in groundbreaking studies on sickle cell disease, infectious diseases and genetic disorders. These efforts are instrumental to improving care for children around the world. St. Jude was the first institution to develop a cure for sickle cell disease with a bone marrow transplant and has one of the largest pediatric sickle cell programs in the country. In addition, St. Jude's brain tumor science and technology are at the cutting edge worldwide, and St. Jude has the largest research-based pediatric brain tumor research program in the country. St. Jude is the coordinating center of the national Pediatric Brain Tumor Consortium, which receives funding from the National Cancer Institute.And St. Jude's efforts to save the lives of cancer patients don't end when treatment stops. The St. Jude After Completion of Therapy (ACT) program is the largest long-term, follow-up clinic for pediatric cancer patients in the United States. The Clinic's accomplishments are now an integral part of national guidelines for screening and managing the late effects of survivors of pediatric cancer. 448914179 1 0 0 1 0 0 0 0 1 1 1 0 0 0 0 0 0 1 1 1 0 1 0 1 0 0 0 0 0 1 1 1 1 1 0 0 0 1 0 0 0 1 1153 48 1 1511 1 1 1 1 BR CH EZ EG FI FR GM GR HK HU IS IT JA KS MY NL NZ PK PE PO RS SP SW SZ TW UK 0 0 1 1 1 1 0 0 0 1 1 46 41 1 0 1 0 0 0 0 1 1 0 1 1 1 1 1 1 1 1 1 1 0 AK AL AR AZ CA CO CT DC DE FL GA HI IA ID IL IN KS KY LA MA MD ME MI MO MS NC ND NE NH NJ NM NV NY OH OK OR PA RI SC MT WA WV WI WY SD TN TX UT VA VT X Jeffrey T Pearson 9015782000 501 St Jude Place Memphis TN 381050000 Joyce Aboussie 6.50 X 0 0 0 Thomas G Abraham 6.50 X 0 0 0 Susan Mack Aguillard MD 6.50 X 0 0 0 Mahir Awdeh MD 6.50 X 0 0 0 Joseph S Ayoub Jr Esq 6.50 X 0 0 0 Paul J Ayoub Esq 6.50 X 0 0 0 James K Barkate 6.50 X 0 0 0 Martha Perine Beard 6.50 X 0 0 0 KATHIE BERLIN 6.50 X 30000 0 0 Sheryl Bourisk 6.50 X 0 0 0 Robert A Breit MD 6.50 X 0 0 0 Terry Burman 6.50 X 0 0 0 Stephen J Camer MD 6.50 X 0 0 0 Tony Charaf 6.50 X 0 0 0 Michael Driebe 6.50 X 0 0 0 Ed Eissey 6.50 X 0 0 0 Fred P Gattas Jr 6.50 X 0 0 0 Fred P Gattas III 6.50 X 0 0 0 Christopher B George MD 6.50 X 0 0 0 Judy Habib 6.50 X 0 0 0 Paul K Hajar 6.50 X 0 0 0 Chuck Hajjar 6.50 X 0 0 0 Fred R Harris 6.50 X 0 0 0 Bruce B Hopkins 6.50 X 0 0 0 Richard Ieyoub 6.50 X 0 0 0 Richard Karam Esq 6.50 X 0 0 0 Salli LeVan 6.50 X 0 0 0 Paul Marcus 6.50 X 0 0 0 Jim Naifeh Jr 6.50 X 0 0 0 Talat M Othman 6.50 X 0 0 0 Thomas Penn III 6.50 X 0 0 0 Manal Saab 6.50 X 0 0 0 Camille F Sarrouf Sr Esq 6.50 X 0 0 0 Camille F Sarrouf Jr Esq 6.50 X 0 0 0 Joseph G Shaker 6.50 X 0 0 0 George A Simon II 6.50 X 0 0 0 Paul J Simon 6.50 X 0 0 0 Edward Soma 6.50 X 0 0 0 Terre Thomas 6.50 X 0 0 0 Tony Thomas 6.50 X 0 0 0 Pat Kerr Tigrett 6.50 X 0 0 0 Richard M Unes 6.50 X 0 0 0 Paul H Wein Esq 6.50 X 0 0 0 Tom Wertz 6.50 X 0 0 0 Ramzi Younis MD 6.50 X 0 0 0 Tama Zaydon 6.50 X 0 0 0 Raymond J Zoghby 6.50 X 0 0 0 WILLIAM E EVANS 1.00 X 0 783379 12159 Richard C Shadyac Jr 55.00 X X 199454 0 11487 David McKee 55.00 X 512670 0 38725 Hollis Nichols 55.00 X 261911 0 38206 Jeffrey Pearson 55.00 X 214967 0 34478 William Reeser 55.00 X 233938 0 39503 Lori O'Brien 55.00 X 216836 0 34460 Diane Spears 55.00 X 233499 0 35500 Emily Greer 55.00 X 220329 0 36010 Marilyn Elledge 55.00 X 218181 0 34868 2341785 783379 315396 87 0 1 0 Infocision Management Corporation 325 Springside Drive Akron OH 443334504 CALL CENTER 4848774 RB Davies Inc 10536 Culver Blvd Suite M Culver City CA 902323423 MARKETING CONSULTANT 1800991 Teksystems PO Box 198568 Atlanta GA 303848568 it Contract labor 1070051 MDS Communications Corporation 545 W Juanita Ave Mesa AZ 852100000 CALL CENTER 916841 VACO Midsouth LLC 5410 Maryland Way 460 Brentwood TN 37027 it Contract labor 818837 33 7327727 1558696 650484398 4233707 659370821 20149588 20149588 49907 49907 49907 49907 204061237 42496 163366003 563158 40695234 -520662 40174572 -520662 40695234 7055656 1558696 2159596 4896060 4896060 21031949 5083256 15948693 15948693 2890214 2057289 832925 832925 741422566 15428031 832925 65790789 408161189 408161189 1478573 208653 500188 769732 58963918 8310742 20117537 30535639 3699643 527642 1221978 1950023 8885826 1016920 3710559 4158347 4313729 611470 1407739 2294520 693947 75245 375159 243543 252425 25291 90350 136784 10006 1003 3581 5422 5992249 5992249 6000115 990364 1870606 3139145 403488 42850 153438 207200 8756547 1346424 5246143 2163980 4630511 443939 1499760 2686812 4493664 510916 812300 3170448 1426460 208264 265380 952816 221 22 188 11 7452491 1064404 4173688 2214399 1221820 136406 374439 710975 Postage & shipping 56523141 13180714 3579532 39762895 Campaign expenses 40407527 9126360 2938212 28342955 Printing & publications 6023106 794197 866783 4362126 Telecommunications 2869928 1192184 1255315 422429 Equip & software maint. 154295 14001 44050 96244 10084515 924979 2579293 6580243 642899334 448914179 53086218 140898937 X 71644330 20292138 3015988 48336204 100323390 85751644 16515794 14406832 4515548 2610074 3695924 2900919 5510848 5248392 105743848 43793010 59306056 61950838 1562677859 1802214563 1752545419 1975083262 15564760 15739544 21124841 22192566 36689601 37932110 X 1092392434 1237134733 32643135 37242519 590820249 662773900 1715855818 1937151152 1752545419 1975083262 X 0 1 1 X 0 X 474395613 555036573 627727112 658106230 659093376 2974358904 474395613 555036573 627727112 658106230 659093376 2974358904 2974358904 21696349 23648108 31062479 25255056 20199495 121861487 2912285 3413003 3428526 1129256 832925 11715995 71590186 143964339 89221425 -15828592 68782839 357730197 3465666583 0.85820 0.84770 X Schedule A, Part IV, Supplemental Information: SCHEDULE A, PART II, LINE 10, EXPLANATION FOR OTHER INCOME: COLUMN (A): 2005 - TOTAL OF $71,590,186 CONSISTS OF: A. GAIN/LOSS ON SALE OF SECURITIES: $42,712,191 B. GROSS FUNDRAISING EVENTS RECEIPTS (LESS CONTRIBUTIONS): $6,687,668 C. GROSS GAMING RECEIPTS: $22,190,327 COLUMN (B): 2006 - TOTAL OF $143,964,339 CONSISTS OF: A. GAIN/LOSS ON SALE OF SECURITIES: $112,726,060 B. GROSS FUNDRAISING EVENTS RECEIPTS (LESS CONTRIBUTIONS): $9,557,112 C. GROSS GAMING RECEIPTS: $21,681,167 COLUMN (C): 2007 - TOTAL OF $89,221,425 CONSISTS OF: A. GAIN/LOSS ON SALE OF SECURITIES: $57,640,595 B. GROSS FUNDRAISING EVENTS RECEIPTS (LESS CONTRIBUTIONS): $8,743,043 C. GROSS GAMING RECEIPTS: $22,837,787 COLUMN (D): 2008 - TOTAL OF ($15,828,592) CONSISTS OF: A. GAIN/LOSS ON SALE OF SECURITIES: ($42,101,258) B. GROSS FUNDRAISING EVENTS RECEIPTS (LESS CONTRIBUTIONS): $6,764,765 C. GROSS GAMING RECEIPTS: $19,507,901 COLUMN (E): 2009 - TOTAL OF $68,782,839 CONSISTS OF: A. GAIN/LOSS ON SALE OF SECURITIES: $40,695,234 B. GROSS FUNDRAISING EVENTS RECEIPTS (LESS CONTRIBUTIONS): $7,055,656 C. GROSS GAMING RECEIPTS: $21,031,949 1 10006 10006 0 590820249 4396601 69032459 1475409 662773900 723150356 10016491 -142346598 590820249 1.00000 1 0 30929918 30929918 23373178 9804779 13568399 1235131 952300 282831 29894525 20474616 9419909 20311096 12561315 7749781 61950838 MARKETABLE ALTERNATIVES 400367290 F CASH 47994467 F DOMESTIC EQUITY 289142276 F FIXED INCOME 285292181 F INTERNATIONAL EQUITY 322721513 F PRIVATE EQUITY 144920232 F REAL ASSETS 311776604 F 1802214563 ANNUITY OBLIGATIONS 22192566 22192566 741422566 642899334 98523232 122772102 122772102 221295334 869798586 122772102 122772102 747026484 -5603918 -5603918 741422566 647982590 5083256 5083256 642899334 0 642899334 Part V, Line 4: Description of Intended Use of Endowment Funds: TO SUPPORT THE CURRENT AND FUTURE NEEDS OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. Part XII, Line 4b - Other Adjustments: Net loss from disposal of property and equipment: -520662. Direct gaming expenses: -5083256. Part XIII, Line 2d - Other Adjustments: Direct gaming expenses: 5083256. PART X, LINE 2 - ALSAC adopted the provisions of Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 740, Income Taxes (formerly FASB Interpretation No. 48, Accounting for Uncertainty in Income Taxes) on July 1, 2009. Application of ASC Topic 740 to a tax-exempt organization is primarily directed at the characterization of income as tax exempt (related or excluded exempt function income) and /or taxable as unrelated business income as defined in the Code. ALSAC evaluated the effect of ASC topic 740 and determined that no adjustments to its financial statements were required upon the adoption of ASC Topic 740 on July 1, 2009. As of June 30, 2010, ALSAC had not identified any uncertain tax positions under ASC Topic 740 requiring adjustments to its financial statements. In the event ALSAC were to recognize interest and penalties related to uncertain tax positions, it would be recognized in the financial statements as a general expense. Generally tax years 2006 through 2009 are open to examination by the federal and state taxing authorities, respectively. There are no income tax examinations currently in process. X X X X X X 1 Infocision Management Corp CALL CENTER (SEE SCH O) 0 5156864 4137361 1019503 MDS Communications Corp CALL CENTER (SEE SCH O) 0 2839441 1313391 1526050 Echo Marketing Solutions Inc CALL CENTER (SEE SCH O) 0 492417 541497 -49080 8488722 5992249 2496473 AK AR AZ CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT WA WV WI WY VT VA AL Gala 1759821 408450 1351371 25892 65119 15192 40650 Gala 471707 22509 449198 3127 44143 94458 23986 16669 86 6382824 1127737 5255087 30727 133680 810433 254776 600744 8614352 1558696 7055656 59746 177823 970010 293954 658063 2159596 4896060 21031949 825000 4258256 0 21031949 825000 4258256 5083256 15948693 CA GA ID IL IN KY LA MO MS MT OH OK TN TX VA WV 1 0 0 0 1.00000 Jeffrey T Pearson 501 St Jude Place Memphis TN 381050000 0 Alan Johnson 94233 Manage the planning and execution of raffle activities X 0 1 ST JUDE CHILDREN'S RESEARCH HOSPITAL INC 262 DANNY THOMAS PLACE MEMPHIS TN 38105 620646012 501(c)(3) 408161189 Operation of Hospital 1 Procedure for Monitoring Grants in the U.S.: Part I, Line 2: Schedule I, Part I, Line 2: The sole recipient of grants and support is St. Jude Children's Research Hospital, Inc. ALSAC is the fundraising organization of St. Jude Children's Research Hospital. ALSAC exists solely to raise and provide the funds necessary to operate and maintain St. Jude. It costs $1.5 million a day to operate St. Jude, and more than 70 percent of St. Jude's operating budget is covered by public contributions generated by ALSAC fundraising programs. X X 1 1 X X X X X 0 0 0 0 0 0 0 0 0 WILLIAM E EVANS 0 648320 0 0 0 135059 0 0 0 12159 0 795538 0 0 Richard C Shadyac Jr 199263 0 0 0 191 0 0 0 11487 0 210941 0 0 0 David McKee 509106 0 0 0 3564 0 26280 0 12445 0 551395 0 0 0 Hollis Nichols 259285 0 0 0 2626 0 25425 0 12781 0 300117 0 0 0 Jeffrey Pearson 214474 0 0 0 493 0 21471 0 13007 0 249445 0 0 0 William Reeser 233093 0 0 0 845 0 24175 0 15328 0 273441 0 0 0 Lori O'Brien 216338 0 0 0 498 0 21679 0 12781 0 251296 0 0 0 Diane Spears 231955 0 0 0 1544 0 23674 0 11826 0 268999 0 0 0 Emily Greer 219818 0 0 0 511 0 22247 0 13763 0 256339 0 0 0 Marilyn Elledge 217410 0 0 0 771 0 21877 0 12991 0 253049 0 0 0 Part I, Line 1a Tax indemnification and gross-up payments: payments made to eligible employees for certain taxable retirement benefits were grossed-up for tax indemnification purposes. Health or social club dues: A social club membership was made available to the CEO but limited to business purposes in accordance with a written policy directive. Part II: William E. Evans serves as a voting director of the board of ALSAC. Dr. Evans is employed as an officer of St. Jude, a related organization to ALSAC. The compensation shown in columns B, D, and E was paid to Dr. Evans by St. Jude for his duties as CEO of St. Jude. Shaker Recruitment Advertising & Communications entity more than 35% owned by Joseph G. Shaker, Director 825109 Advertising Services. Director Joseph Shaker's family foundation provides an additional donation in an amount that matches two-thirds of the standard agency commission paid on traditional media purchases by the organization. 0 Kelley Habib John Innovative Marketing Inc entity more than 35% owned by Judy Habib, Director 114525 Consulting Services 0 Sarah Heinz Family member of Hollis Nichols, Officer 36266 Employment 0 Mike Fowler Family member of David McKee, Officer 65512 Employment 0 X 17 X 8 X 3 X 422 3240867 COST OR SELLING PRICE X 1 992840 COST OR SELLING PRICE X 82 X Other Prizes 253 X Prize Package 286 X Gift CERT. 225 X Miscellaneous 16 2 0 1 0 Method for Determining Number of Contributors: Part I, Column (b): Line 1 - Art - Works of art - revenues are included in Form 990, Part VIII, lines 8a (fundraising events) and 9a (gaming). Line 5 - Clothing and household goods - revenues are included in Form 990, Part VIII, lines 8a (fundraising events) and 9a (gaming). Line 6 - Cars and other vehicles - revenues are included in Form 990, Part VIII, lines 8a (fundraising events) and 9a (gaming). Line 7 - Boats and planes - revenues are included in Form 990, Part VIII, lines 8a (fundraising events) and 9a (gaming). Line 18 - Collectibles - revenues are included in Form 990, Part VIII, lines 8a (fundraising events) and 9a (gaming). Line 25 - Other prizes - revenues are included in Form 990, Part VIII, lines 8a (fundraising events) and 9a (gaming). Line 26 - Prize packages - revenues are included in Form 990, Part VIII, lines 8a (fundraising events) and 9a (gaming). Line 27 - Gift certificates - revenues are included in Form 990, Part VIII, lines 8a (fundraising events) and 9a (gaming). Line 28 Miscellaneous - revenues are included in Form 990, Part VIII, lines 8a (fundraising events) and 9a (gaming). Form 990, Part VI, Section A, line 2 Family relationships among directors: Joseph S. Ayoub, Jr., Paul J. Ayoub, Robert A. Breit, MD, Fred P. Gattas, Jr., Fred P. Gattas, III, Camille F. Sarrouf, Sr., Camille F. Sarrouf, Jr., Joseph G. Shaker, George A. Simon II, Paul J. Simon, Tony Thomas, Terre Thomas. Business relationships among directors: Robert A. Breit, MD and Joseph G. Shaker. Form 990, Part VI, Section A, line 4 The Board approved to change the requirement of a 3/4 majority Board vote to approve purchase of real estate to a 2/3 majority. The Board approved adding the following subsection with regard to Emeritus members: (i) the member shall be of good moral character to be eligible to be elected to and maintain Emeritus status and (ii) members elevated to Emeritus status continue to be subject to the removal provisions of Article IV, Section 8.The Board approved the position of the Epsilon Sigma Alpha member would be as an honorary non-voting position. The Board approved the CEO of ALSAC and the Director and CEO of the Hospital as ex-officio members, to have voting rights. The Board approved members of the Nominating Committee shall be the Chairs of the ALSAC and St. Jude Boards and three other full voting board members, having been an active member of the Board for a minimum of five consecutive years. The Chairs of ALSAC and St. Jude Board current at the time shall serve as voting ex-officio members of the committee, but may not participate in any discussions or vote concerning his/her relating as Chair. The Board approved the increase in term limits of officers of ALSAC (St. Jude) shall serve more than two (2) successive years in the same office. With a favorable recommendation of the Nominating Committee, the Board may elect by secret ballot such officer for a third and fourth one (1) year consecutive term by a 3/4 majority vote of the full Board in attendance. The Board approved the appointment of the new list of Standing Committees. The name of the Quality Improvement Committee is now Quality Assurance and Patient Care Committee. The Board approved to delete Article IV Section 7 in its entirety and replace it with the following: "No member shall remain on the Board of Directors unless such member attends annually at least three (3) meetings of the Board of Directors, except where good cause or special circumstance is shown for the member's absence. "Good cause" or "special circumstance" shall be determined at the discretion of the Membership Screening Committee in consultation with the Board Chair. Any member who wishes to participate in an in-person meeting telephonically must submit their request 1 day prior to the meeting to the Committee Chair. All members participating by telephone or electronic device shall be deemed present. Voting by members attending telephonically or electronically must vote publically or abstain. Voting by Secrets ballots may be done by submitting their vote via email to the person presiding over the meeting. The Second Vice Chairman shall assume the duties of the First Vice Chairman if that office becomes vacant in the middle of a term. In the event of the ascension to the position of First Vice Chair, death, resignation, removal or other disability of the Second Vice Chairman, the Nominating Committee will meet to develop a recommendation for a successor. The proposed recommendation will be presented at the next meeting of the Board of Governors. Form 990, Part VI, Section B, line 11 In February of each year, the audit committee and officers of the board are provided with a draft copy of Form 990 and all required schedules. The audit committee meets with its tax preparer to review the draft Form 990 before it is filed with IRS. Additionally, the compensation committee of the board receives a draft copy of the compensation sections of Form 990 for review before it is filed with IRS. Each voting member of the board receives a final copy of Form 990 with all required schedules before it is filed with IRS. Form 990, Part VI, Section B, line 12c The organization maintains an ad hoc conflict of interest committee of the board of directors. In addition to education of new board members on the conflict of interest policy, the executive administrator to the board actively monitors conflict management plans (which may include changing vendors, divestiture of financial interests, and the like) to ensure they are completed in a timely fashion. Undisclosed conflicts are discovered, where possible, through the organization's contracting process. This is true for the board's conflict of interest policy and for the separate conflict of interest policy applicable to all employees of the organization (potential conflicts of the organzation are discussed and resolved at a senior-level conflicts of interest committee). Potential restrictions range from unwinding or prohibiting a transaction, to preventing someone from participating in a deliberation, to simple disclosure to the board of the conflicting interest, depending on the facts and circumstances of the conflict. Form 990, Part VI, Section B, line 15 The executive compensation committee of the board commissions regular salary surveys for the CEO, CFO, COO, Chief development officer, Chief Legal Officer and Chief Investment Officer. Form 990, Part VI, Section C, line 19 Governing documents, conflicts of interest policy, and financial statements are available to the public upon request. Schedule G, Part I, Line 2b, Column (v) Explanation of Fundraising Payments Engagements with professional fundraisers are related mostly to acquisition programs targeting monthly giving. The comparison of new receipts and amounts paid to fundraisers in the tax year omits the value of contributions to be received in future years. FORM 990, PART VII Compensation of Kathie Berlin, Director: Compensation was for marketing consulting services and not related to duties performed as a director. Schedule J-2 Part I Richard C. Shadyac, Jr., CEO & Ex-officio director: Compensation reported on Schedules J and J-2 are for performance of services as CEO and not related to duties as an ex-officio director. Schedule J-2 Part I DAVID Mckee, COO and Interim CEO: Compensation reported on schedules J and J-2 Includes compensation for performance of services as interim CEO along with performance of services as COO. Schedule J-2, Part I William E. Evans serves as a voting director of the Board of ALSAC. Dr. Evans is employed as an officer of St. Jude, a related organization to ALSAC. The compensation shown in column (E) was paid to Dr. Evans by St. Jude for his duties as CEO of St. Jude. Form 990, Part V, Line 4b List of Foreign Countries: The financial accounts in the foreign countries listed on Form 990, Part V, Line 4b (and Schedule O) are related to investments. No financial accounts for operational purposes were maintained in foreign countries. Form 990, Part I, Line 13 Grants and Similar Amounts Paid (Part IX, Column (A), Lines 1-3): The sole recipient of grants and support is St. Jude Children's Research Hospital, Inc., a related organization governed by a common board of directors and governors. Form 990, Part VII, Line 9 Gross income from gaming activities: Gaming activities consist entirely of Dream Campaign Raffles. ST JUDE CHILDREN'S RESEARCH HOSPITAL INC 262 DANNY THOMAS BLVD MEMPHIS TN 381050000 620646012 HOSPITAL TN SECTION 501(C)(3) SECTION 170 (B)(1)(a N/A 0 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 0 ST JUDE CHILDREN'S RESEARCH HOSPITAL INC B 408161189 ST JUDE CHILDREN'S RESEARCH HOSPITAL INC K 408161189 ST JUDE CHILDREN'S RESEARCH HOSPITAL INC O 934777 ST JUDE CHILDREN'S RESEARCH HOSPITAL INC P 51102